Ownership

Mark Anthony McCamish - Director at Avadel Pharmaceuticals Plc

Insider Transactions and Holdings

Entity Type: Individual
Role: Director
Stock Symbol: AVDL on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Mark Anthony McCamish - trading volume in the past year for Avadel Pharmaceuticals Plc

	Shares	%	Avg Price	Total $
Buys
Sells	-75K	100%	$14.53	-$1.09M
Net	-75K	-100%		-$1.09M

Holdings reported by Mark Anthony McCamish for Avadel Pharmaceuticals Plc

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
ADSs	67K	$972K	$14.50	Dec 28, 2023	By Matthew 5 LLC
Ordinary Shares	67K	$683K	$10.19	Jul 30, 2024	By Matthew 5 LLC
Ordinary Shares	11K	$112K	$10.19	Jul 30, 2024	Direct
Stock Option (Right to Buy)	11K			Jul 30, 2024	Direct	Ordinary Shares

Transactions reported by Mark Anthony McCamish for Avadel Pharmaceuticals Plc

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.